Evidence map›Paper›PMID 31658259›Full record

ArticlePLoS genetics2019

The comprehensive role of E-cadherin in maintaining prostatic epithelial integrity during oncogenic transformation and tumor progression.

Adam Olson, Vien Le, Joseph Aldahl, Eun-Jeong Yu, Erika Hooker, Yongfeng He, Dong-Hong Lee, Won Kyung Kim, Robert D Cardiff, Joseph Geradts and 1 more

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. E-cadherin expression is inversely correlated with aging and inflammation in the prostate.American journal of clinical and experimental urology · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Adam OlsonDepartment of Cancer Biology, Beckman Research Institute, City of Hope, Duarte, California, United States of America.ORCID 0000-0003-3118-0393
Vien LeDepartment of Cancer Biology, Beckman Research Institute, City of Hope, Duarte, California, United States of America.
Joseph AldahlDepartment of Cancer Biology, Beckman Research Institute, City of Hope, Duarte, California, United States of America.ORCID 0000-0001-9664-5644
Eun-Jeong YuDepartment of Cancer Biology, Beckman Research Institute, City of Hope, Duarte, California, United States of America.ORCID 0000-0002-2118-2128
Erika HookerDepartment of Cancer Biology, Beckman Research Institute, City of Hope, Duarte, California, United States of America.ORCID 0000-0002-4515-4041
Yongfeng HeDepartment of Cancer Biology, Beckman Research Institute, City of Hope, Duarte, California, United States of America.
Dong-Hong LeeDepartment of Cancer Biology, Beckman Research Institute, City of Hope, Duarte, California, United States of America.ORCID 0000-0001-7466-6997
Won Kyung KimDepartment of Cancer Biology, Beckman Research Institute, City of Hope, Duarte, California, United States of America.
Robert D CardiffCenter for Comparative Medicine, University of California at Davis, Davis, California, United States of America.
Joseph GeradtsDepartment of Population Sciences, Beckman Research Institute, City of Hope, Duarte, California, United States of America.
Zijie SunDepartment of Cancer Biology, Beckman Research Institute, City of Hope, Duarte, California, United States of America.ORCID 0000-0002-6787-6272
City of Hope · USUniversity of California, Davis · US

Funding

Transgenic Mouse FacilityP30CA033572 · NCI · CITY OF HOPE/BECKMAN RESEARCH INSTITUTE · PI XIWEI WU · 1985 to 2026
$86.3M
Roles of the androgen receptor and its co-regulators in prostate tumorigenesisR01CA070297 · NCI · STANFORD UNIVERSITY · PI SUN, ZIJIE · 2003 to 2025
$5.0M
Wnt responsive stem cells in the prostateR01DK104941 · NIDDK · STANFORD UNIVERSITY · PI SUN, ZIJIE · 2015 to 2024
$3.0M
A new regulator for Wnt/beta-catenin signaling and prostate tumorigenesisR01CA151623 · NCI · STANFORD UNIVERSITY · PI SUN, ZIJIE · 2011 to 2015
$1.7M
A New Mechanism for Castration Resistant Prostate CancerR01CA166894 · NCI · STANFORD UNIVERSITY · PI SUN, ZIJIE · 2015 to 2018
$1.2M
Cellular And Molecular Properties Of PINs In Prostate TumorigenesisR21CA190021 · NCI · STANFORD UNIVERSITY · PI SUN, ZIJIE · 2014 to 2016
$401k
NCI NIH HHS P30 CA033572NCI NIH HHS R01 CA070297NCI NIH HHS R01 CA151623NCI NIH HHS R01 CA166894NCI NIH HHS R21 CA190021NIDDK NIH HHS R01 DK104941
6 · The paper itself

Abstract

E-cadherin complexes with the actin cytoskeleton via cytoplasmic catenins and maintains the functional characteristics and integrity of the epithelia in normal epithelial tissues. Lost expression of E-cadherin disrupts this complex resulting in loss of cell polarity, epithelial denudation and increased epithelial permeability in a variety of tissues. Decreased expression of E-cadherin has also been observed in invasive and metastatic human tumors. In this study, we investigated the effect of E-cadherin loss in prostatic epithelium using newly developed genetically engineered mouse models. Deletion of E-cadherin in prostatic luminal epithelial cells with modified probasin promoter driven Cre (PB-Cre4) induced the development of mouse prostatic intraepithelial neoplasia (PIN). An increase in levels of cytoplasmic and nuclear β-catenin appeared in E-cadherin deleted atypical cells within PIN lesions. Using various experimental approaches, we further demonstrated that the knockdown of E-cadherin expression elevated free cytoplasmic and nuclear β-catenin and enhanced androgen-induced transcription and cell growth. Intriguingly, pathological changes representing prostatic epithelial cell denudation and increased apoptosis accompanied the above PIN lesions. The essential role of E-cadherin in maintaining prostatic epithelial integrity and organization was further demonstrated using organoid culture approaches. To directly assess the role of loss of E-cadherin in prostate tumor progression, we generated a new mouse model with bigenic Cdh1 and Pten deletion in prostate epithelium. Early onset, aggressive tumor phenotypes presented in the compound mice. Strikingly, goblet cell metaplasia was observed, intermixed within prostatic tumor lesions of the compound mice. This study provides multiple lines of novel evidence demonstrating a comprehensive role of E-cadherin in maintaining epithelial integrity during the course of prostate oncogenic transformation, tumor initiation and progression.

Indexed as

AnimalsAntigens, CDbeta CateninCadherinsCell Line, TumorCell ProliferationCell Transformation, NeoplasticDisease Models, AnimalDisease ProgressionEpithelial CellsEpitheliumHEK293 CellsHumansMaleMiceMice, TransgenicAntigens, CDbeta CateninCadherinsCDH1 protein, humanCdh1 protein, mouseCTNNB1 protein, mousePTEN PhosphohydrolasePten protein, mouseRNA, Small Interfering

Identifiers

PMID31658259
PMCPMC6816545
OpenAlexW2981347255

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.